Very little is currently known about the pathophysiology of pruritus sine materia according to the etiology. The creation of this cohort should make it possible to improve our clinical and biological knowledge according to the etiology, by collecting blood, skin, feces, and clinical data.
At inclusion, 52.5 ml of blood will be collected, then an additional skin biopsy and a skin swab. Five questionnaires will be filled in by the patient. At 6 months, then every years for 5 years, the same 5 questionnaires will be collected as well as the clinical data. However, no more biological samples will be collected.
Study Type
OBSERVATIONAL
Enrollment
175
At inclusion : * 52.5 ml of blood : * 24 ml plasma * 20 ml serum * 6 ml DNA * 2.5 ml RNA
At inclusion a skin swab sample will be collected
At inclusion a skin biopsy sample will be collected
Service de dermatologie, CHRU BREST
Brest, France
RECRUITINGClinical description of the pruritus
Chronology
Time frame: 5 years
Clinical description of the pruritus
Intensity
Time frame: 5 years
Clinical description of the pruritus
Location
Time frame: 5 years
Clinical description of the pruritus
Aggravating and ameliorating factors
Time frame: 5 years
Clinical description of the pruritus
Evolution
Time frame: 5 years
Clinical description of the pruritus
Scratching
Time frame: 5 years
Clinical description of the pruritus
Chronology, intensity, location, aggravating and ameliorating factors, evolution, scratching
Time frame: 5 years
5-D itch scale questionnaire
The scores for each of the five domains (duration, degree, direction, disability, ditribution) are calculated separately and then added together to obtain a total 5-D score. The 5-D score can range from 5 (no pruritus) to 25 (most severe pruritus). Scores with a single item (duration, degree, direction) are equal to the value indicated by the answer choice (from 1 to 5). The impact of pruritus (disability) includes four items that assess the impact of itching on daily activities: sleep, leisure activities, social activities, domestic activities, work/study. The score for impact is reached by taking the highest score on any of the four items. For location (distribution), the number of body parts affected is collected (potential sum of 0 to 16) and the sum is classified into 5 scores: * sum of 0 to 2 = score of 1 * sum of 3 to 5 = score of 2 * sum of 6 to 10 = score of 3 * sum of 11 to 13 = score of 4 * sum of 14 to 16 = score of 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
At inclusion, at 6 months and every year, the patient will respond to 5 questionnaires : Brest questionnaire, 5-D itch scale, Dermatology Life Quality Index, Itchy Quality of Life and Hospital Anxiety and Depression Scale
Time frame: 5 years
Dermatology Life Quality Index questionnaire (DLQI)
DLQI = Dermatology Life Quality Index is a ten-item questionnaire. The score ranges from 0 to 30. Each question is rated from 0 to 3. The higher the score, the worse the health status. Interpretation of DLQI: DLQI scores 0-1: no effect on patient's life DLQI scores 2-5: small effect on patient's life DLQI scores 6-10: moderate effect on patient's life DLQI scores 11-20: very large effect on patient's life DLQI scores 21-30: extremely large effect on patient's life
Time frame: 5 years
Hospital anxiety and depression questionnaire (HAD)
The HAD scale is an instrument to screen for anxiety and depressive disorders. It consists of 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus making it possible to obtain two scores (maximum score for each score = 21). To screen for anxiety and depressive symptoms, the following interpretation can be proposed for each of the scores (A and D) * 7 or less: no symptomatology * 8 to 10: doubtful symptomatology * 11 and more: definite symptomatology.
Time frame: 5 years
Brest Questionnaire
The Brest questionnaire is a descriptive tool. No score is calculated.
Time frame: 5 years